CDI Faculty

Helena Kraemer

Helena Kraemer, Ph.D.

Dr. Kraemer's research focuses on research methods in the behavioral aspects of medicine. Her work has expanded from psychiatry and health psychology to other fields including cardiology, epidemiology, pediatrics, and oncology. Currently, she is concerned with problems arising in risk research, particularly related to moderation and mediation, as well as effect sizes that are both clinically and practically interpretable and statistically valid.

Positions

  • Professor Emerita of Biostatistics in Psychiatry, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA
  • Professor of Psychiatry, Department of Psychiatry, University of Pittsburgh School of Medicine

 

Education

  • Ph.D., 1963, Stanford University, Statistics

 

Relevant Publications

  • Kraemer HC, Frank E, Kupfer DJ. How to assess the clinical impact of treatments on patients, rather than the statistical impact of treatments on measures. Int J Methods Psychiatr Res. 2011;20(2):63-72.
  • Kraemer HC, Kupfer DJ, Narrow WE, Clarke DE, Regier DA: Moving towards DSM-5: The field trials. Am J Psychiatry. 2010;167(10):1158-1160. Kraemer HC. The usefulness of mathematical models in assessing medical tests. Epidemiology. 2010;21(1): 139-141. Frank E, Cassano GB, Rucci P, Thompson WK, Kraemer HC, Fagiolini A, Maggi L, Kupfer DJ, Shear MK, Houck PR, Calugi S, Grochocinski VJ, Scocco P, Buttenfield J, Forgione RN. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychol Med. 2010;12:1-12.
  • Kraemer HC, Frank E, Kupfer DJ. Moderators of treatment outcomes: Clinical, research, and policy importance. JAMA. 2006;296:1-4.